Upcoming events on NOVAVAX, INC. |
|
03/01/21 | | FY 2020 Earnings Release (Projected) |
05/12/21 | | Q1 2021 Earnings Release (Projected) |
08/10/21 | | Interim 2021 Earnings Release (Projected) |
11/10/21 | | Q3 2021 Earnings Release (Projected) |
|
Past events on NOVAVAX, INC. |
|
01/11/21 | 08:20am | | JP Morgan Healthcare Conference |
01/08/21 | 11:00am | | Biotech Showcase Investor Conference |
12/03/20 | 02:15pm | | Evercore ISI HealthCONx Conference |
12/02/20 | | Investor Meeting |
|
Upcoming sector events for NOVAVAX, INC. |
|
|
|
Past sector events for NOVAVAX, INC. |
|
|
|
Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales M $ |
Released Forecast Spread | 36,3 38,8 -6,5% | 15,4 15,3 0,26% | 31,2 28,7 8,5% | 34,3 35,3 -2,8% | 18,7 11,8 58% | 520
|
Operating income (EBITDA) M $ |
Released Forecast Spread |
|
| -154 -149 -3,8% | -166 -158 -4,6% |
|
|
Operating profit (EBIT) M $ |
Released Forecast Spread | -157 -119 -32% | -269 -273 1,5% | -172 -168 -2,1% | -174 -172 -1,3% | -130 -121 -7,5% | -306
|
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -157 -117 -34% | -280 -284 1,5% | -184 -180 -2,3% | -185 -182 -1,4% | -133 -128 -3,9% | -340
|
Net income M $ |
Released Forecast Spread | -157 -117 -34% | -280 -285 1,6% | -184 -180 -2,0% | -185 -182 -1,4% | -133 -130 -2,4% | -314
|
EPS $ |
Released Forecast Spread | -12,0 -8,96 -34% | -20,6 -21,0 2,0% | -12,6 -12,4 -1,5% | -10,0 -10,2 2,4% | -5,51 -5,42 -1,6% | -5,49
| Announcement Date | 02/29/2016 | 02/27/2017 | 03/14/2018 | 03/18/2019 | 03/11/2020 | |
|
|
Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales M $ |
Released Forecast Spread | 10,8 10,0 7,6% | 7,74 9,63 -20% | 6,13 7,09 -14% | 3,98 4,60 -13% | 3,36 3,06 9,5% | 2,51 3,32 -24% | 8,82 2,98 195% | 3,38 1,93 75% | 35,5 39,6 -10% | 157 231 -32% | 324
| 764
| 807
| 852
| 797
|
Operating income (EBITDA) M $ |
Released Forecast Spread | -42,0 -43,0 2,2% | -41,9 -46,0 9,0% | -46,5 -44,2 -5,3% | -40,2 -45,2 11% | -36,7 -35,0 -4,9% | -24,0 -20,4 -18% | -28,7 -24,1 -19% | -22,9 -33,7 32% | -17,0 -16,8 -1,4% | -194 113 -272% | -71,9
| 327
| 317
| 411
| 446
|
Operating profit (EBIT) M $ |
Released Forecast Spread | -44,5 -45,7 2,6% | -44,6 -48,8 8,6% | -49,3 -46,7 -5,5% | -43,2 -46,3 6,6% | -39,6 -37,9 -4,6% | -18,0 -23,3 23% | -31,8 -24,6 -29% | -25,9 -36,3 29% | -17,5 -17,7 0,99% | -197 88,1 -324% | -99,4
| -98,3
| -98,7
| 487
| 811
|
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -44,5 -45,7 2,6% | -44,6 -48,8 8,6% | -49,3 -46,8 -5,4% | -43,2 -46,4 6,9% | -39,6 -38,3 -3,5% | -18,0 -20,7 13% | -31,8 -27,0 -18% | -25,9 -36,9 30% | -17,5 -35,0 50% | -197 109 -280% | -73,8
| 246
| 239
| 374
| 380
|
Net income $ |
Released Forecast Spread | -2,40 -2,46 2,6% | -2,40 -2,52 4,8% | -2,60 -2,39 -9,0% | -2,20 -2,26 2,6% | -1,69 -1,59 -6,4% | -0,74 -0,92 19% | -1,13 -1,05 -7,9% | -0,58 -0,71 19% | -0,30 -0,53 44% | -3,21 1,73 -285% | -1,20
| 2,44
| 2,41
| 3,37
| 3,87
| Announcement Date | 08/08/2018 | 11/07/2018 | 03/18/2019 | 05/02/2019 | 08/07/2019 | 11/07/2019 | 03/11/2020 | 05/11/2020 | 08/10/2020 | 11/09/2020 | | | | | |
|
Financial data source © 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
Logistics firms reap "vaccine economy" benefits as EU gears up for roll-out |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|